Table 4.
SNP & study | Country | Ethnicity | Genotyping method | Source of cases | Sample size | Case | Control | p of HWE | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | AA | AG | GG | AA | AG | GG | ||||||
rs895819 | |||||||||||||
Sun et al. 2010 | China | Asian | PCR-RFLP | HB | 304 | 304 | 115 | 135 | 54 | 145 | 119 | 40 | 0.05 |
Zhou et al. 2012 | China | Asian | MassARRAY | HB | 295 | 413 | 166 | 122 | 7 | 214 | 167 | 32 | 0.94 |
Song et al. 2014 | China | Asian | Direct Sequencing | HB | 278 | 278 | 105 | 124 | 49 | 131 | 111 | 36 | 0.11 |
GG | AG | AA | GG | AG | AA | ||||||||
rs11671784 | |||||||||||||
Song et al. 2014 | China | Asian | Direct Sequencing | HB | 278 | 278 | 128 | 122 | 28 | 100 | 134 | 44 | 0.93 |
Yang et al. 2014 | China | Asian | TaqMan | HB | 892 | 978 | 398 | 414 | 80 | 371 | 487 | 120 | 0.12 |
HWE – Hardy-Weinberg equilibrium; PCR-RFLP – polymerase chain reaction-restriction fragment length polymorphism; HB – hospital based of control.